期刊文献+

Endothelial progenitor cells as factors in neovascularization and endothelial repair 被引量:7

Endothelial progenitor cells as factors in neovascularization and endothelial repair
在线阅读 下载PDF
导出
摘要 Endothelial progenitor cells(EPCs)are a heterogeneous population of cells that are provided by the bone marrow and other adult tissue in both animals and humans.They express both hematopoietic and endothelial surface markers,which challenge the classic dogma that the presumed differentiation of cells into angioblasts and subsequent endothelial and vascular differentiation occurred exclusively in embryonic development.This breakthrough stimulated research to understand the mechanism(s)underlying their physiologic function to allow development of new therapeutic options.One focus has been on their ability to form new vessels in injured tissues,and another has been on their ability to repair endothelial damage and restore both monolayer integrity and endothelial function in denuded vessels.Moreover,measures of their density have been shown to be a better predictor of cardiovascular events,both in healthy and coronary artery disease populations than the classical tools used in the clinic to evaluate the risk stratification.In the present paper we review the effects of EPCs on revascularization and endothelial repair in animal models and human studies,in an attempt to better understand their function,which may lead to potential advancement in clinical management. Endothelial progenitor cells (EPCs) are a heterogeneous population of cells that are provided by the bone marrow and other adult tissue in both animals and humans. They express both hematopoietic and endothelial surface markers, which challenge the classic dogma that the presumed differentiation of cells into angioblasts and subsequent endothelial and vascular differentiation occurred exclusively in embryonic development. This breakthrough stimulated research to understand the mechanism(s) underlying their physiologic function to allow development of new therapeutic options. One focus has been on their ability to form new vessels in injured tissues, and another has been on their ability to repair endothelial damage and restore both monolayer integrity and endothelial function in denuded vessels. Moreover, measures of their density have been shown to be a better predictor of cardiovascular events, both in healthy and coronary artery disease populations than the classical tools used in the clinic to evaluate the risk stratification. In the present paper we review the effects of EPCs on revascularization and endothelial repair in animal models and human studies, in an attempt to better understand their function, which may lead to potential advancement in clinical management.
出处 《World Journal of Cardiology》 CAS 2010年第12期411-420,共10页 世界心脏病学杂志(英文版)(电子版)
基金 Supported by Grants from American Heart Association grant-in-aid,No.0455435B American Heart Association SDG,No. 110350047A NIH Grant No.RO1-HL077566 and No.RO1-HL085119 to Zhang C
关键词 Atherosclerosis Bone MARROW ENDOTHELIAL dysfunction ENDOTHELIAL PROGENITOR CELLS NEOVASCULARIZATION Stem CELLS Atherosclerosis Bone marrow Endothelial dysfunction Endothelial progenitor cells Neovascularization Stem cells
  • 相关文献

参考文献105

  • 1Li-BoChen Xiao-BingJiang LianYang.Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells[J].World Journal of Gastroenterology,2004,10(20):3016-3020. 被引量:94
  • 2Huangfu D,Osafune K,Maehr R,Guo W,Eijkelenboom A,Chen S,Muhlestein W,Melton DA.Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology . 2008
  • 3Ko K,Tapia N,Wu G,Kim JB,Bravo MJ,Sasse P,Glaser T,Ruau D,Han DW,Greber B,Hausdrfer K,Sebastiano V,Ste- hling M,Fleischmann BK,Brüstle O,Zenke M,Schler HR.Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell . 2009
  • 4Assmus B,Sch chinger V,Teupe C,Britten M,Lehmann R,D bert N,Grünwald F,Aicher A,Urbich C,Martin H,Hoelzer D,Dimmeler S,Zeiher AM.Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation . 2002
  • 5Duong Van Huyen JP,Smadja DM,Bruneval P,Gaussem P,Dal-Cortivo L,Julia P,Fiessinger JN,Cavazzana-Calvo M,Aiach M,Emmerich J.Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Modern Pathology . 2008
  • 6Feygin J,Mansoor A,Eckman P,Swingen C,Zhang J.Func- tional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplan- tation. American Journal of Physiology Heart and Circulatory Physiology . 2007
  • 7Kawamoto A,Katayama M,Handa N,Kinoshita M,Takano H,Horii M,Sadamoto K,Yokoyama A,Yamanaka T,On- odera R,Kuroda A,Baba R,Kaneko Y,Tsukie T,Kurimoto Y,Okada Y,Kihara Y,Morioka S,Fukushima M,Asahara T.Intramuscular transplantation of G-CSF-mobilized CD34 (+) cells in patients with critical limb ischemia:a phase I/IIa, multicenter,single-blinded,dose-escalation clinical trial. Stem Cells . 2009
  • 8Mund JA,Ingram DA,Yoder MC,Case J.Endothelial pro- genitor cells and cardiovascular cell-based therapies. Cyto- therapy . 2009
  • 9Perin EC,Dohmann HF,Borojevic R,Silva SA,Sousa AL,Mesquita CT,Rossi MI,Carvalho AC,Dutra HS,Dohmann HJ,Silva GV,Belém L,Vivacqua R,Rangel FO,Esporcatte R,Geng YJ,Vaughn WK,Assad JA,Mesquita ET,Willerson JT.Transendocardial,autologous bone marrow cell transplan- tation for severe,chronic ischemic heart failure. Circulation . 2003
  • 10Martin-Rendon E,Brunskill SJ,Hyde CJ,Stanworth SJ,Mathur A,Watt SM.Autologous bone marrow stem cells to treat acute myocardial infarction:a systematic review. European Heart Journal . 2008

二级参考文献33

  • 1Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose - competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003; 111:843-850.
  • 2Kolb H, Burkart V. Nicotinamide in type 1 diabetes. Mechanism of action revisited. Diabetes Care 1999; 22(Suppl 2):B16-20.
  • 3Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA.Insulin staining of ES cells progeny from insulin uptake. Science 2003; 299:363.
  • 4Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2000; 416:542-545.
  • 5Spees JL, Olson SD, Ylostalo J, Lynch PJ, Smith J, Perry A,Peister A, Wang MY, Prockop DJ. Differentiation, cell fusion,and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A 2003; 100: 2397-2402.
  • 6Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 2001; 50:1691-1697.
  • 7Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK.Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002; 99:16105-16110.
  • 8Shiroi A, Yoshikawa M, Yokota H, Fukui H, Ishizaka S, Tatsumi K, Takahashi Y. Identification of insulin-producing cells derived from embryonic stem cells by zinc-chelating dithizone.Stem Cells 2002; 20:284-292.
  • 9Kim D, Gu Y, Ishii M, Fujimiya M, Qi M, Nakamura N,Yoshikawa T, Sumi S, Inoue K. In vivo functioning and transplan table mature pancreatic islet-like cell clusters differentiated from embrvonic stem cell. Pancreas 2003; 27:E34-E41.
  • 10Deutsch G', Jung J, Zheng M, Lora J, Zaret KS. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 2001; 128:871-881.

共引文献132

同被引文献37

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部